Avalo Therapeutics, Inc. (AVTX)

CIK 1534120 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avalo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026S-3ASR0001104659-26-123072
Nov 5, 2026SCHEDULE 13G/A0000315066-26-002679
Nov 5, 20268-K0001534120-26-000056
Nov 5, 20268-K0001104659-26-123079
Nov 5, 202610-Q0001534120-26-000057
Nov 5, 2026424B50001104659-26-123069
Oct 29, 2026SCHEDULE 13G0001493152-26-049273
Oct 2, 202640001707797-26-000017
Oct 2, 202640002063957-26-000009
Oct 2, 202640001677036-26-000009
Sep 18, 202640001810417-26-000023
Sep 11, 202640001810417-26-000021
Sep 1, 202640001918845-26-000031
Aug 19, 202640001810417-26-000019
Aug 19, 202640001918845-26-000029
Aug 18, 20261440001950047-26-008317
Aug 17, 20261440001950047-26-008220
Aug 17, 20261440001950047-26-008276
Aug 17, 20261440001950047-26-008273
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003460
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097285
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000918
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002164
Aug 14, 2026SCHEDULE 13G/A0001897612-26-000606
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000021